John L. Bishop

Chief Executive Officer Mr. Bishop joined us as Chief Executive Officer and as a director in April 2002. Mr. Bishop served as President and a director of Vysis, a genomic disease management company from 1993 to 2002 and as Chief Executive Officer from 1996 to March 2002. From 1991 until November 1993, Mr. Bishop was Chairman and Chief Executive Officer of MicroProbe Corporation, a biotechnology company and, from 1987 until 1991, of Source Scientific Systems, a biomedical instrument manufacturing company. From 1984 to 1986, Mr. Bishop was President and Chief Operating Officer of Gen-Probe, Inc. From 1968 to 1984, Mr. Bishop held various management positions with American Hospital Supply Company and its affiliates, including a three-year assignment in Japan as an Executive Vice President and Chief Executive Officer of International Reagents Corp., a joint venture between American Hospital Supply Company and Green Cross Corporation.

David H. Persing, M.D., Ph.D.

Executive Vice President, Chief Medical & Technology Officer Dr. Persing first joined us as a director in May 2004, and then became our Executive Vice President and Chief Medical and Technology Officer in August 2005. Dr. Persing was previously Senior Vice President and Chief Scientific Officer at Corixa Corporation, a Seattle-based biotechnology company, until their acquisition by GlaxoSmithkline in July 2005. From 1990 to 1999 he was a member of the Clinical and Research Faculty of the Mayo Clinic in Rochester, Minnesota where he research programs on hepatitis viruses and tick-borne infections. In 1992 he founded and directed the Molecular Microbiology Laboratory at Mayo Clinic, which pioneered many of the diagnostic techniques used in molecular pathology laboratories today. He has authored over 240 peer-reviewed articles and served as Editor in Chief for 3 textbooks on Molecular Diagnostics, the most recent of which was published by ASM press in December 2004.

Humberto Reyes

Executive Vice President, Operations Mr. Reyes joined us as Senior VP, Operations in November 2004 and was promoted to Executive Vice President, Operations in December of 2006. Prior to joining Cepheid, Mr. Reyes was an Operations Consultant with Brownsboro Group, LLC. from September 2003 to November 2004. Prior to joining Brownsboro, Mr. Reyes was a Senior Operations Consultant for EXPERTech Associates, consulting in medical devices and biotech industries from November 2001 to June 2003. Prior to that, he was Head of Operations for OXIS Health Products Inc., which developed, manufactured and marketed products for oxidative research and wellness programs from August 1997 to September 2001. He is an experienced operations executive with more than 25 years of progressive management experience in the diagnostic and related industries. Mr. Reyes' work experience also includes Vice President, Operations, Dade Diagnostics at Baxter; Vice President/General Manager, Chromatography Division, Varian and Associates; and Sr. Vice President, Operations, Microgenics Corporation.

Peter J. Dailey, Ph.D.

Senior Vice President, Research and Development Dr. Dailey was promoted to the position of Senior Vice President, Research and Development in February 2008, having joined us as Vice President, Research and Development, in June 2006. Most recently, Dr. Dailey was the Senior Director of the Department of Infectious Disease in Discovery Research at Roche Molecular Systems, Inc. He is a microbiologist and virologist by training and has worked in the field of diagnostic microbiology for the last 25 years. Dr. Dailey worked as a Public Health Microbiologist at the California State Dept. of Health’s Viral & Rickettsial Disease Laboratory in Berkeley in the 1980s on the development of diagnostic assays for HIV ant HTLV. He also worked many years as a Clinical Laboratory microbiologist in medical centers, hospitals, and reference laboratories. Beginning in 1990, he was employed at Chiron Diagnostics (now Bayer Diagnostics) working on the research, development, and application of nucleic acid probe assays, in particular viral load assays for HCV, HIV, and SIV. He has served as a subcommittee member on the NCCLS committee revising Guidelines for Molecular Diagnostic Methods for Infectious Diseases and has authored or co-authored more than 35 peer-reviewed papers as well as several book chapters and reviews on infectious disease nucleic acid diagnostic assays.

Russel K. Enns, Ph.D.

Senior Vice President, Regulatory, Clinical & Government Affairs & Quality Systems Dr. Enns joined us as Senior Vice President, Regulatory Affairs, Quality System, Clinical Affairs and Medical Reimbursement in June 2003. Prior to joining Cepheid, Dr. Enns was Divisional Vice President for Regulatory Affairs, Quality System, Clinical Affairs and Medical Reimbursement at Vysis, Inc. a genomic disease management company from 1995 to April 2003. Before joining Vysis, he was Vice President, Technical Affairs of MicroProbe Corporation, a biotechnology company, from 1992 to 1995. Before joining MicroProbe Corporation, he was Director of Product Development, Clinical Programs and Technical Affairs at GenProbe, Inc., a biotechnology diagnostic company, from 1984 to 1992. From 1979 to 1984, Dr. Enns was the Director of Cell Biology at Alpha Therapeutics Corporation, and from 1975 to 1979 he was a Senior Biochemist at Monsanto Corporation. He received his Ph.D. in Biochemistry from University of California at Davis in 1976. Dr. Enns is a charter member and past chair of the CLSI (formerly NCCLS) Area Committee on Molecular Methods, and he is currently a member of the CLSI Board of Directors.

Robert J. Koska

Senior Vice President, Worldwide Commercial Operations Mr. Koska joined us as Senior VP, Sales & Marketing in February 2005, and assumed the title of Senior VP, Worldwide Commercial Operations in September 2007. Prior to joining Cepheid, Mr. Koska held various positions with Vysis, Inc. and subsequently Abbott Laboratories since 1996. Mr. Koska's work experience includes Divisional Vice President, Vysis U.S. and Canadian Sales at Abbott Molecular Diagnostics, and Senior Vice President Worldwide Sales & Marketing, Vysis prior to the Abbott acquisition. Mr. Koska further previously held progressive positions in sales and marketing at DIFCO Laboratories, Inc., Bristol Myers Genetic Systems Corporation, and J&J's Ortho Diagnostic Systems, Inc. Mr. Koska has an MBA, Marketing Emphasis, from the University of Michigan, Ann Arbor, MI, and a BS degree in Medical Technology from Wayne State University, Detroit, MI. Mr. Koska is an experienced sales and marketing executive with more than 25 years of progressive management experience in the diagnostic industry.

Andrew D. Miller

Senior Vice President, Chief Financial Officer Mr. Miller joined us in April 2008 as Senior Vice President, Chief Financial Officer. Prior to joining Cepheid, Mr. Miller was Vice President and Chief Accounting Officer for Autodesk where he led Autodesk's worldwide accounting, compliance, SEC reporting, and Sarbanes-Oxley 404 activities. Before joining Autodesk, Mr. Miller was Senior Vice President and CFO for MarketFirst Software, Inc., a leading provider of enterprise marketing automation software. Additional previous experience includes tenures as Vice President of Worldwide Finance for Cadence Design Systems, Vice President of Finance and Corporate Controller for Adaptive Broadband Corporation, and senior financial roles for SGI. Mr. Miller graduated Summa Cum Laude from Santa Clara University with a Bachelors of Science in Commerce and holds a CPA from the state of California.

Joseph H. Smith, C. Phil

Senior Vice President, Legal/Business Development Mr. Smith joined us in June 2003 and now serves as Sr. Vice President and General Counsel. He has been Secretary of the Corporation since March 2004. From 1989 to April 2002, Mr. Smith was Vice President of Intellectual Property at Applied Biosystems Group and its predecessors, a biotechnology research equipment company, and during 2002-2003 was its Senior Vice President for Business Development. Prior to Applied Biosystems, Mr. Smith was a partner in the law firm of Wiseman, Jones, and Smith; he was also a memeber of the Technical Legal Department of Hewlett-Packard.

Nicki Bowen

Vice President, Engineering Nicki Bowen became Vice President, Engineering in August 2004. Joining Cepheid in 1999, she had previously held the positions of Director, Software and System Integration, and Director, Software Engineering. Before Cepheid, Ms. Bowen was Director of Instrument Development, Dade Behring, San Jose. She has held a variety of progressive engineering and engineering management positions in the diagnostics and laboratory equipment industries, including positions at Behring Diagnostics, Syva, and Hamilton Company.

Lee Christel, Ph.D.

Vice President, Research and System Integration Dr. Christel has a Ph.D. in Applied Physics and over 20 years of commercial experience in developing micromachined devices, integrated instrumentation, and fluidic systems, and transferring them to production. He has been with Cepheid since its inception in 1996. He was formerly Vice President of Product Engineering at Redwood Microsystems, responsible for new product development of fluidic control systems. As a senior research staff member and Manager of Technology Development at Lucas NovaSensor from 1988 to 1993, he brought a range of micromachined products to market, including pressure sensors, accelerometers, and microwave power detectors.

Rika Dutau

Vice President and Managing Director of Cepheid Europe Rika Dutau joined Cepheid in October 2007 as Vice President and Managing Director of Cepheid Europe. Mrs. Dutau joins the company with over 16 years of experience in the start-up and the development of commercial operations in Europe. Prior to joining Cepheid, Mrs. Dutau held a variety of senior management, sales, marketing, and business development roles in the medical device and critical care industries, including that of Vice President and General Manager for Teleflex Medical where she was responsible for the surgical business units across Europe, the Middle-East, and Africa. Mrs. Dutau holds a Masters degree in Pharmaceutical Sciences from the University of Ghent, Belgium.

Sandra Finley

Vice President, Marketing Ms. Finley joined us in September 2006 as Vice President, Marketing. Prior to joining Cepheid, Ms. Finley was Sr. Director, Market Development for Molecular Diagnostics at Affymetrix. Prior to Affymetrix, she has held a variety of progressive sales and marketing positions in the diagnostic industry, including positions at Abbott Molecular Diagnostics/Vysis, Sysmex Corporation, and Cardinal Healthcare (Allegiance/Baxter Healthcare). She has more than 20 years experience in the clinical diagnostic industry.

Rick Fletcher

Vice President, Regulatory Compliance and Quality Systems Mr. Fletcher joined us in April 2007 as Vice President, Regulatory Compliance and Quality Systems. Prior to joining Cepheid, Mr. Fletcher was Director, Molecular Diagnostics Operations for Veridex, LLC a Johnson & Johnson company. At Veridex he was a member of the team that developed and manufactured the recently FDA approved GeneSearch BLN Test Kit which utilizes the Cepheid SmartCycler. Mr. Fletcher has held positions at Gen-Probe, Roche Molecular Systems, ID Biomedical, Amersham Pharmacia, Johnson & Johnson Clinical Diagnostics and Biosense Webster. Mr. Fletcher has more than 20 years experience in the clinical diagnostic industry in the areas of R&D, Quality Control, Operations and Quality Assurance.

Kerry Flom, Ph.D.

Vice President, Clinical Affairs and Regulatory Submissions Most recently, Dr. Flom was Sr. Director, Clinical Affairs and Regulatory Submission for Abbott Molecular Diagnostics (2001-2004). Prior to Abbott, Dr. Flom directed the clinical affairs departments at Vysis, Inc., Baxter Healthcare Corporation - Cardiovascular Group (presently Edwards Lifesciences), and Oncor Inc. Before joining Oncor, Dr. Flom has held clinical and R&D positions at Boehringer Mannheim Corporation (presently Roche Diagnositics), Behring Diagnostics, and Ciba Corning.

Anita Herrström-Sjöberg

Vice President & Managing Director - Cepheid AB Anita Herrström Sjöberg joined Cepheid in 2007 as Vice President and Managing Director of Cepheid AB. Prior to joining Cepheid she was a Production Director and a member of the management team for Sangtec Molecular Diagnostics which Cepheid acquired in 2007. Mrs. Herrström Sjöberg started at Sangtec Medical in 1999. Sangtec Medical became Sangtec Molecular Diagnostics in 2001. Mrs. Herrström Sjöberg has 10 years of experience in biochemistry, recombinant constructions and expression systems from the Nobel Institute at the Royal Karolinska Institute, Stockholm. She defended her thesis at the Swedish University of Agricultural Sciences, Uppsala. Prior to joining Sangtec, she was working as a consultant in leadership training and team building.

Laurie King

Vice President, Human Resources Ms. King was promoted to Vice President, Human Resources in June 2004, having joined Cepheid in January 2003. Prior to joining Cepheid Ms. King held the positions of Vice President, Human Resources for Incyte, Risk Management Solutions, and the American Electronics Association. Ms. King has over 20 years experience in Human Resources, is a member of the Bay Area Human Resources Executive Council, and serves as West Coast co-chair of the 2008 BIO HR Conference.

Michael Myhre

Vice President, Corporate Controller Mr. Myhre joined us as Vice President, Corporate Controller, in January 2007. Prior to joining Cepheid, Mr. Myhre was Corporate Controller for Packeteer, a leading provider in WAN Application Delivery systems and before that he was Vice President of Finance for Equator Technologies, a privately held, fabless semiconductor company. In addition, he has held management positions at Symantec and VLSI Technologies since beginning his career at KPMG International. Mr. Myhre has over twenty years of experience in various Finance and Accounting related areas and he holds a B.S. in Accounting from Santa Clara University and is a Certified Public Accountant.

Vincent M. Powers

Vice President, Intellectual Property Mr. Powers joined us as Vice President of Intellectual Property in April 2007. Most recently, he was Director of Chemical Patent Practice with the Applied Biosystems Group of Applera Corporation, where he worked as a patent attorney from 1999 until March 2007. Prior to working at ABI, he was a patent agent and then patent attorney with Dehlinger & Associates in Palo Alto from 1992 to 1999. He received a B.S. in Chemistry from Caltech, a Ph.D. in Pharmaceutical Chemistry from UCSF, and a J.D. from Santa Clara University School of Law.

Jan Steuperaert

Vice President, Information Technology Mr. Steuperaert became Vice President, Information Technology in June 2007. Joining Cepheid in 2002, he has previously participated in setting up and developing the European subsidiary, where he held the position of Managing Director. Prior to joining Cepheid, he was Managing Director of the European division of Vysis inc., and has held a variety of management positions in the medical device industry, including Teleflex. Mr. Steuperaert is a design engineer for Aeronautics, from the Ecole Nationale Supérieure d’Ingénieurs de Constructions Aéronautiques in Toulouse, France.

Emily S. Winn-Deen, Ph.D.

Vice President, R&D, Genetics and Oncology Dr. Winn-Deen came to Cepheid from Roche Molecular Systems in Pleasanton, CA where she led the genomics business group where her team created the overall market strategy and individual business plans for each of that group's diagnostic products. Her career has included development of clinical chemistry reagents, urinalysis strips, immunoassays, and DNA diagnostics. At Applied Biosystems, Dr. Winn-Deen managed the team developing a DNA diagnostic for cystic fibrosis, and as director of diagnostics R&D at Oncor, Inc. she led the team developing novel DNA-based cancer assays including the first FDA approved test for HER2/neu. While at Celera Genomics she established their high-throughput genotyping laboratory, and then directed their genotyping services business. Dr. Winn-Deen received her B.S. in Chemistry from Lehigh University, her Ph.D. in Chemistry from Boston University, and has over 25 years of experience in diagnostics product development.